Stocksigma LogoStocksigma Logo

Alembic Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 2,603 (+36.3% YoY | +21.1% QoQ) ■ EBITDA: 563 (+78.4% YoY | +69.7% QoQ) ■ EBITDA Margin (%): 21.6 (+511 bps YoY | +620 bps QoQ) ■ PAT: 335

Alembic Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Alembic Pharmaceuticals Ltd · Outcome · 04 Nov 2026, 7:56 pm

Alembic Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 2,603 (+36.3% YoY | +21.1% QoQ) ■ EBITDA: 563 (+78.4% YoY | +69.7% QoQ) ■ EBITDA Margin (%): 21.6 (+511 bps YoY | +620 bps QoQ) ■ PAT: 335 (+81.5% YoY | +93.7% QoQ) ■ EPS (INR): 17.1 (+81.4% YoY | +93.7% QoQ)

Original exchange filing (PDF)

More announcements from Alembic Pharmaceuticals Ltd

All Alembic Pharmaceuticals Ltd announcements